Elicio Therapeutics Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +77.7% | -523.8% | – | – | – | – | – | – | – | |
| – | -0.6% | -99.6% | +24,700.0% | +26.6% | -60.0% | +320.4% | +10.7% | +0.7% | -4.2% | |
| – | – | – | – | +109.9% | +102.9% | -6.3% | +103.6% | +23.2% | +85.7% | |
| – | – | – | – | +115.4% | +276.3% | +282.9% | – | – | – | |
| – | – | +828.3% | +215.7% | +164.3% | -96.6% | -117.2% | – | – | -187.0% | |
| – | -63.2% | -100.0% | – | -83.1% | +1,181.4% | +24.5% | -89.9% | +31.8% | -81.6% | |
| – | +41.6% | – | – | -83.1% | +1,181.4% | +24.5% | -95.1% | +162.5% | -81.0% | |
| – | – | – | – | -90.4% | – | – | – | +266.0% | – | |
| – | – | – | – | +0.0% | +0.0% | -100.0% | – | +97.3% | -100.0% | |
| – | +173.0% | – | -84.6% | +971.8% | -63.0% | +9.3% | +82.1% | +9.6% | -13.3% | |
| – | +11.0% | +3,493.2% | -185.0% | – | -117.5% | – | – | -11.8% | -104.5% | |
| – | +84.3% | -527.8% | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.